Fate Therapeutics gets IP from two tech transfers
Fate Therapeutics (stem cell technology) has licensed exclusive rights to intellectual property jointly owned by Children's Hospital Boston and Massachusetts General Hospital pertaining to compositions and methods of supporting hematopoietic stem cells.
- Gene Therapy, Cell Therapy
- Large Molecule
- Includes Contract
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com